P. mansouri[8]
|
Iran
|
Sinopharm
|
49
|
woman
|
3 d
|
second dose
|
2 weeks
|
Fexofenadine
Topical violet gentian
|
M. Elboraey[9]
|
Saudi Arabia
|
Pfizer
|
Middle-aged
|
woman
|
5 d
|
first dose
|
2 weeks
|
prednisolone (30 mg/d),
Oral corticosteroids in the form of a mouthwash.
|
L. Boualila[10] |
morocco |
Sinopharm |
32 |
man |
6 hours |
second
dose |
30 days |
eye drops and ointment, oral
doxycycline. |
S. Dash[11] |
India |
AstraZeneca |
49 |
woman |
3 d |
First dose |
7 days |
Cyclosporine 300 mg |
M. Bakir[12] |
Iran |
Pfizer |
60 |
woman |
7 d |
First dose |
22
days |
Etanercept 50 mg/ml, 2 doses on the first and second day of
admission marked healing in 22 days |
A. Kherlopian
[13]
|
Australia
|
AstraZeneca
|
48
|
Woman
|
14 d
|
First dose
|
28 days
|
adalimumab
|
M. Mardani
[14]
|
Iran
|
Sinopharm
|
76
|
man
|
1 d
|
First dose
|
2 weeks
|
prednisolone and prepared mouthwash.
|
C. Aimo [15] |
Italy |
AstraZeneca |
65 |
Man |
3 d |
Second dose |
8 weeks |
prednisolone 1mg/Kg/day |
P. Mansouri [16] |
Iran |
Sinopharm |
63 |
Woman |
1 d |
N/A |
2
weeks |
Oral prednisolone (40mg) daily |
s.shakoei |
Iran |
Sinopharm |
67 |
man |
6 d |
First dose |
2 weeks |
Dexamethasone, Cyclosporine |